Success once again for Handelsbanken’s International Healthcare Conference

Report this content

Around 100 institutional investors from all over the world took part in Handelsbanken’s annual healthcare conference focusing on innovation, to discuss research and development with senior management from twelve of the currently most attractive healthcare companies.

This year, those participating included the world-famous Alzheimers research scientist and professor, Lars Lannfelt, founder of BioArctic, and the Chairman, President and CEO of Thermo Fisher Scientific, Marc Casper.

“The conference is an important part of Handelsbanken’s ambition to offer value-creating insights and meeting places”, says Mattias Häggblom, who leads Handelsbanken’s successful team of healthcare research analysts.

Handelsbanken was organising the conference for the third successive year. It was led by healthcare analyst Mattias Häggblom who, together with his team Suzanna Queckbörner and Rickard Anderkrans, cover the sector.

“The healthcare sector is a prioritised area for both the Bank and our customers. We are therefore pleased that we, together with several of the most innovative research companies, have succeeded over three years in establishing an internationally sought-after conference, which creates significant opportunities for our customers and the Bank alike,” says Christer Beckard, Global Head of Equities at Handelsbanken Capital Markets.

What makes the conference unique is the mix of knowledgeable investors from both Europe and the US with major mandates and the high-profile company representatives, as well as the opportunity for in-depth discussions led by Handelsbanken’s top-ranked healthcare analysts.

“We are seeing a growing international interest in participating from both investors and companies. Our focus on innovation doesn’t only generate interesting discussions. We also know that the most innovative companies have a sound basis for creating profitable investments over time,” says Mattias Häggblom.

The following companies participated in Handelsbanken Life Science Innovation Day 2023:

Sobi, Guido Oelkers, CEO Sobi
Biotage Olof Nord, EVP Business Development
AstraZeneca, Mene Pangalos, Executive Vice President Biopharma R&D
Getinge, Mattias Perjos, CEO
Coloplast, Anders Lonning Skovgaard, CFO & EVP
Bonesupport, Emil Billbäck, CEO
Guest Speaker, Professor, MD Lars Lannfelt, co-founder of BioArctic
Lundbeck, Johan Luthman, EVP & Head R&D
AddLife, Fredrik Dalborg, CEO
Camurus, Fredrik Tiberg, CEO
Elekta, Gustaf Salford, CEO
Thermo Fisher Scientific, Marc Casper, Chairman, President & CEO

Enquiries from the media, please contact Handelsbanken’s Press Office:
+46(0)8-7018018

Subscribe

Media

Media

Documents & Links